V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10004055 | 10002560 | 1.69 | 65.4 | Palliative (P) | 2015-02-21 | 2015-04-09 | Abiraterone | N | Y | 10506660 | TEMOZOLOMIDE + RT |
| 10004056 | 10002561 | 1.78 | 90.3 | Palliative (P) | 2013-07-03 | 2013-07-11 | Chlorambucil | 02 | N | 10506662 | ABVD |
| 10004057 | 10002561 | 1.6 | 100 | Palliative (P) | 2015-12-13 | 2015-12-19 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10506662 | CHLORAMBUCIL |
| 10004058 | 10008154 | 1.52 | 58.2 | Adjuvant (A) | 2016-05-30 | 2016-05-30 | Temozolomide + RT | 2 | N | 10506691 | EC |
| 10004059 | 10002562 | 1.73 | 63.7 | Adjuvant (A) | 2016-09-28 | 2016-10-26 | FLUOROURACIL | N | N | 10506707 | FLUOROURACIL |
| 10004060 | 10002563 | 1.57 | null | Palliative (P) | 2019-01-05 | 2019-01-12 | Temozolomide + RT | 2 | N | 10506721 | ABIRATERONE |
| 10004061 | 10002563 | 1.62 | 67 | Palliative (P) | 2017-12-04 | 2017-12-04 | FLUOROURACIL + IRINOTECAN | N | N | 10506721 | IRINOTECAN + MDG |
| 10004062 | 10002564 | 1.52 | 51.6 | Palliative (P) | 2015-07-30 | 2015-08-13 | Azacitidine | 02 | Y | 10506744 | CTD |
| 10004063 | 10002565 | null | 81 | Curative (C) | 2018-02-07 | 2018-02-07 | BCG Intravesical | N | N | 10506765 | BCG |
| 10004064 | 10002566 | 1.53 | 52.7 | Curative (C) | 2016-01-10 | 2016-01-29 | Chlorambucil | N | Y | 10506788 | CAPECITABINE + CISPLATIN |
| 10004065 | 10002566 | 1.8 | 84.5 | Disease modification (D) | 2015-01-01 | 2015-01-01 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 10506788 | BORTEZOMIB |
| 10004066 | 10002566 | 1.8 | 94.2 | Curative (C) | 2018-02-07 | 2018-03-03 | Fluouracil continuous infusion | N | N | 10506788 | FLUOROURACIL |
| 10004067 | 10008826 | 1.51 | 78 | null | 2013-12-04 | 2013-12-27 | ABVD | N | N | 10506951 | CTD |
| 10004068 | 10009109 | null | 76.2 | Neo-adjuvant (N) | 2017-02-19 | 2017-03-08 | Capecitabine 35days + RT | N | Y | 10506952 | CAPECITABINE + RT |
| 10004069 | 10002567 | 0 | 73 | Neo-adjuvant (N) | 2018-03-22 | 2018-03-22 | IMATINIB | N | N | 10506983 | ABVD |
| 10004070 | 10002568 | null | null | Neo-adjuvant (N) | null | 2014-01-28 | Capecitabine 35days + RT | N | Y | 10506991 | CAPECITABINE + RT |
| 10004071 | 10002569 | 1.67 | 89 | Unknown (U) | 2016-08-01 | 2016-08-02 | BCG Intravesical | null | N | 10506992 | CISPLATIN + ETOPOSIDE |
| 10004072 | 10002570 | 1.72 | 83.1 | Adjuvant (A) | 2019-01-15 | 2019-01-22 | FEC 100 + DOCETAXEL | 02 | N | 10506999 | FEC + DOCETAXEL |
| 10004073 | 10002571 | null | 85.7 | Palliative (P) | 2018-05-16 | 2018-05-16 | Fluorouricil + Folonic Acid (MdG) | null | N | 10507008 | FLUOROURACIL |
| 10004074 | 10002572 | 1.79 | 76 | Disease modification (D) | 2013-04-27 | 2013-05-20 | FLUOROURACIL + MITOMYCIN + RT | 02 | Y | 10507066 | CVD |
| 10004075 | 10002573 | 1.76 | 75.8 | Palliative (P) | 2018-08-05 | 2018-08-10 | BCG Intravesical | 2 | N | 10507092 | BCG |
| 10004076 | 10006572 | 1.7 | 83 | Curative (C) | 2016-08-18 | 2016-08-19 | CAPECITABINE + GEMCITABINE | N | N | 10507158 | CHOP |
| 10004077 | 10002574 | 1.82 | 80 | Adjuvant (A) | 2015-10-09 | 2015-10-10 | Azacitidine | N | Y | 10507167 | EC |
| 10004078 | 10002575 | 1.89 | 81.1 | Palliative (P) | 2015-06-08 | 2015-06-08 | CAPECITABINE + GEMCITABINE | N | N | 10507187 | IMATINIB |
| 10004079 | 10002576 | 1.6 | null | Disease modification (D) | 2018-06-24 | 2018-06-25 | CTD Attenuated (Thalidomide 50mg) | 2 | N | 10507264 | CTD |
| 10004080 | 10002577 | 1.61 | 56.5 | Curative (C) | 2013-08-18 | 2013-09-13 | Paclitaxel 7 day | N | N | 10507266 | IMATINIB |
| 10004081 | 10002578 | 1.68 | 76.6 | Curative (C) | 2016-04-26 | 2016-05-26 | Temozolomide + RT | 02 | N | 10507270 | CVD |
| 10004082 | 10006573 | 1.76 | 79.6 | Palliative (P) | 2013-10-27 | 2013-11-11 | Imatinib 400mg | N | N | 10507318 | CAPECITABINE + CISPLATIN |
| 10004083 | 10006573 | 0 | 55 | Adjuvant (A) | 2018-03-14 | 2018-04-09 | CHOP - 21 days | 02 | N | 10507318 | CAPECITABINE + CISPLATIN |
| 10004084 | 10002579 | 1.71 | 71 | Palliative (P) | null | 2018-03-08 | Abiraterone | N | N | 10507380 | PACLITAXEL |
| 10004085 | 10002580 | null | 55.8 | Disease modification (D) | 2019-04-18 | 2019-04-21 | FLUOROURACIL + MITOMYCIN + RT | N | null | 10507458 | CISPLATIN + ETOPOSIDE |
| 10004086 | 10002581 | null | 59 | Palliative (P) | 2013-08-30 | 2013-09-16 | Capecitabine + Cisplatin | 02 | N | 10507483 | ABIRATERONE |
| 10004087 | 10002582 | 1.56 | 0 | Palliative (P) | 2019-03-22 | 2019-03-28 | ABVD | N | N | 10507517 | CHLORAMBUCIL |
| 10004088 | 10002583 | 1.7 | 81.3 | Curative (C) | 2019-02-03 | 2019-02-03 | Abiraterone | N | N | 10507529 | EC |
| 10004089 | 10002584 | null | 111 | Disease modification (D) | 2017-10-08 | 2017-10-22 | Capecitabine + Cisplatin | 02 | N | 10507543 | TEMOZOLOMIDE + RT |
| 10004090 | 10002585 | 1.74 | null | Curative (C) | 2013-09-14 | 2013-10-03 | CISPLATIN + ETOPOSIDE | 02 | N | 10507589 | CTD |
| 10004091 | 10002586 | 1.55 | 83.5 | Curative (C) | 2018-09-18 | 2018-09-18 | Chlorambucil | N | N | 10507600 | ABIRATERONE |
| 10004092 | 10002587 | 1.69 | 74 | Palliative (P) | 2018-12-03 | 2018-12-19 | Irinotecan + Modified De Gramont | 2 | N | 10507613 | IRINOTECAN + MDG |
| 10004093 | 10002588 | 1.71 | 124 | Curative (C) | 2018-04-04 | 2018-04-05 | Imatinib 400mg | N | Y | 10507620 | PACLITAXEL |
| 10004094 | 10002588 | 1.71 | 0 | Palliative (P) | 2016-02-15 | 2016-02-25 | Chlorambucil | N | N | 10507620 | CTD |
| 10004095 | 10002589 | null | 85.2 | Adjuvant (A) | 2018-08-26 | 2018-08-26 | Capecitabine + Cisplatin | N | N | 10507739 | BCG |
| 10004096 | 10002590 | 1.65 | 74.8 | Palliative (P) | 2017-12-21 | 2017-12-22 | Fluorouracil + Folinic Acid Weekly | 02 | Y | 10507760 | FLUOROURACIL |
| 10004097 | 10008157 | 1.75 | null | Adjuvant (A) | 2016-03-09 | 2016-03-13 | FEC + DOCETAXEL | N | N | 10507777 | FEC + DOCETAXEL |
| 10004098 | 10002591 | 1.71 | 0 | Curative (C) | 2016-03-16 | 2016-04-11 | Cisplatin + Radiotherapy | 99 | Y | 10507822 | CISPLATIN + RT |
| 10004099 | 10006575 | null | 77.3 | Curative (C) | 2018-01-19 | 2018-02-04 | Cisplatin + Radiotherapy | N | Y | 10507854 | CISPLATIN + RT |
| 10004100 | 10002592 | 1.61 | 122.7 | Palliative (P) | 2017-02-28 | 2017-03-09 | Bortezomib +/- Dexamethasone | 02 | N | 10507871 | CAPECITABINE + CISPLATIN |
| 10004101 | 10006576 | 1.5 | 74.8 | Curative (C) | 2017-02-23 | 2017-02-24 | CISPLATIN + ETOPOSIDE | N | N | 10507941 | CISPLATIN + ETOPOSIDE |
| 10004102 | 10002593 | 1.69 | 100 | Palliative (P) | 2018-10-11 | 2018-11-03 | BCG Intravesical | 02 | N | 10507944 | CAPECITABINE + GEMCITABINE |
| 10004103 | 10006577 | 1.62 | 0 | null | 2018-07-14 | 2018-07-14 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 10508024 | FLUOROURACIL |
| 10004104 | 10002594 | 1.62 | 82.6 | Disease modification (D) | 2015-03-06 | 2015-03-16 | Azacitidine | 02 | N | 10508049 | BORTEZOMIB |